Catalog Number RMS-060024-R |
Device Problem
Occlusion Within Device (1423)
|
Patient Problems
Calcium Deposits/Calcification (1758); Occlusion (1984)
|
Event Date 10/27/2016 |
Event Type
Injury
|
Manufacturer Narrative
|
As of 16/nov/2016 the complaint device has not yet been received at cirl for a lab evaluation; therefore a documentation based investigation has been carried out.The complaint file will be updated with the lab evaluation findings upon receipt of the complaint device.The customers complaint was confirmed based on customer testimony.The stent involved in this complaint was in dwelling for approximately five months.A definitive root cause of this complaint could not be conclusively determined as device use, anatomical conditions and storage and transport conditions could not be replicated.It should be noted that the instructions for use state the following in the ¿warnings¿ section: ¿individual variations of interaction between stents and the urinary system are unpredictable¿ and "change in urine viscosity may hamper drainage".The ifu also states that " the use of this device should be based upon consideration of risk/ benefit factors as they apply to your patient" and "patients should be checked at regular intervals utilizing techniques such as abdominal x-ray (kub film).Patients using calcium supplements must be closely monitored for possible stent encrustation.The stent must be removed if encrustation hampers drainage." the customer was asked if the patient was using calcium supplementation; however to date, it is unknown if the patient was using calcium supplementation.Potential adverse events associated with indwelling ureteral stent listed on the ifu include: * diminished urine drainage/ stent occlusion, * stent encrustation, * hydronephrosis, * pyuria (due to infection).A review of the relevant manufacturing records for the rms-060024-r device could not be performed as the lot number was not provided.Complaints of this nature will continue to be monitored for potential emerging trends.
|
|
Event Description
|
The stent had calcified and blocked the kidney.The stent was replaced.
|
|
Manufacturer Narrative
|
The customer complaint device was received at cirl.The stent was found to be encrusted with a large calcium deposit/ stone on the end of the pigtail.The engineers in the lab evaluation noted that encrustation is patient related and not device related.The stent was snipped at either end and encrustation was visible inside at the potential point of contact with the bladder and kidney.The encrustation may have caused the blockage in the kidney with may have resulted in pain.The stent involved in this complaint was in dwelling for approximately five months.A definitive root cause of this complaint could not be conclusively determined as anatomical/physiological conditions could not be replicated; however this occurrence is most likely attributed to patient physiology.It should be noted that the instructions for use state the following in the ¿warnings¿ section: ¿individual variations of interaction between stents and the urinary system are unpredictable¿ and "change in urine viscosity may hamper drainage".The ifu also states that " the use of this device should be based upon consideration of risk/ benefit factors as they apply to your patient" and "patients should be checked at regular intervals utilizing techniques such as abdominal x-ray (kub film).Patients using calcium supplements must be closely monitored for possible stent encrustation.The stent must be removed if encrustation hampers drainage." the customer was asked if the patient was using calcium supplementation; however to date, it is unknown if the patient was using calcium supplementation.Potential adverse events associated with indwelling ureteral stent listed on the ifu include: diminished urine drainage/ stent occlusion, stent encrustation, hydronephrosis, pyuria (due to infection).A review of the relevant manufacturing records for the rms-060024-r device could not be performed as the lot number was not provided.Complaints of this nature will continue to be monitored for potential emerging trends.
|
|
Event Description
|
A follow-up mdr is being submitted to include the device evaluation details.The stent had calcified and blocked the kidney.
|
|
Search Alerts/Recalls
|